Effect of a Non-Calcium-Based Phosphate Binder on Fibroblast Growth Factor 23 in Chronic Kidney Disease

Publisher： Karger

E-ISSN： 1660-2110|123|1-2|61-66

ISSN： 1660-2110

Source： Nephron Clin Pract, Vol.123, Iss.1-2, 2013-06, pp. : 61-66

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Is Fibroblast Growth Factor-23 a novel marker for phosphate burden in chronic kidney disease with prognostic implications?

By Bielesz Bernhard  

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 194-197

Springer Publishing Company

Access to resources Recommend Favorite

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

By Manghat P.   Fraser W.   Wierzbicki A.   Fogelman I.   Goldsmith D.   Hampson G.  

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1853-1861

Springer Publishing Company

Access to resources Recommend Favorite

A prospective study of fibroblast growth factor-23 in children with chronic kidney disease

By Magnusson Per   Hansson Sverker   Swolin-Eide Diana  

Scandinavian Journal of Clinical and Laboratory Investigation, Vol. 70, Iss. 1, 2010-02 ,pp. : 15-20

Informa Healthcare

Access to resources Recommend Favorite

Fibroblast Growth Factor 23/Klotho Axis in Chronic Kidney Disease

By  

Nephron Clin Pract, Vol. 128, Iss. 1-2, 2014-11 ,pp. : 1-10

Karger

Access to resources Recommend Favorite

Fibroblast Growth Factor 23 in Hemodialysis Patients: Effects of Phosphate Binder, Calcitriol and Calcium Concentration in the Dialysate

By  

Nephron Clin Pract, Vol. 117, Iss. 1, 2010-08 ,pp. : c74-c82

Karger

Access to resources Recommend Favorite